Heart transplantation (HTx) is a procedure which is hindered by several complications. The HEARTS registry aims to allow the analysis of risk factors of all post-HTx complications. It consists in an exhaustive data collection at the moment of inclusion, i.e. HTx, knowing that patients underwent a full-fledged evaluation beforehand to evaluate their aptitude to being transplanted. Post-HTx complications include but is not limited to: all-cause mortality, AMR, ACR, CAV, AKI, sepsis, cancer, psychological disorders, metabolic disorders.
Heart transplantation (HTx) is a procedure which is hindered by several complications. The HEARTS registry aims to allow the analysis of risk factors of all post-HTx complications. It consists in an exhaustive data collection at the moment of inclusion, i.e. HTx, knowing that patients underwent a full-fledged evaluation beforehand to evaluate their aptitude to being transplanted. Post-HTx complications include but is not limited to: all-cause mortality, AMR, ACR, CAV, AKI, sepsis, cancer, psychological disorders, metabolic disorders. To do so, patients are routinely monitored several times per year, the frequency of which depends on the proximity to the HTx. An endomyocardial biopsy is performed 3 times per month starting on day 15 until day 65 after HTx, then once every 20 days until four months, then monthly until six months, then once every 45 days until year 1, and every 3 months thereafter until year 2. Afterwards, they become twice per year until year 5, then once a year. An echocardiography is performed for every visit, with a complete blood analysis, including HLA antibodies screening with DSA evaluation, virologic evaluation. A coronarography is performed for the anniversary year of HTx, then once every 2 years.
Study Type
OBSERVATIONAL
Enrollment
566
All-cause mortality
all-cause mortality
Time frame: up to five years after inclusion
Acute cellular rejection (ACR)
ACR, biopsy-proven
Time frame: up to five years after inclusion
Antibody mediated rejection (AMR)
AMR, biopsy-proven
Time frame: up to five years after inclusion
Acute kidney injury (AKI)
AKI, defined by a KDIGO criteria
Time frame: up to five years after inclusion
Severe sepsis or septic shock
As defined by Surviving Sepsis Campaign
Time frame: up to five years after inclusion
Cardiac allograft vasculopathy (CAV)
CAV, defined ISHLT
Time frame: up to five years after inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.